R2, iCAD patent dispute ends without infringement

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
A panel of arbitrators has cleared computer assisted detection iCAD, Inc. from patent infringement charges brought by rival R2 Technology that a year ago alleged that two of its breast cancer detection patents were being infringed (Case No. 13133Y00865 “R2 Technology and Shih-Ping Wang vs. iCAD”).  
“This is a tremendous win not just for iCAD,” stated W. Scott Parr, iCAD’s president and CEO, “but for the premise that computer aided detection should be affordable and accessible to all women at risk of breast cancer.”
In response to the arbitration commenced by R2, iCAD asserted in a counterclaim that R2 infringed several iCAD patents. The arbitrators found that R2 did not infringe on those patents.

See related story: http://www.healthimaging.com/content/view/1263/89/